Page results
-
Wes Streeting, health and social care secretary, and Jess Phillips, minister for safeguarding, joined Sadiq Khan, mayor of London, and Kaya Comer-Schwartz, deputy mayor for policing and crime, at UCLH’s Lighthouse to announce a national roll-out of Child Houses to all NHS regions.
-
We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
-
How UCLH uses clinical data in research.
-
The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
Read more about the Halcyon linear accelerator, aimed at making cancer treatment faster, more comfortable, and more precise for patients.
-
Dr Patrick Murphy is a consultant clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery.
-
Update about our hospital on Gray's Inn Road
File results
-
FOI/2022/0385 - Stillbirths and infant deaths
-
FOI/2022/0386 - Permanent/ International Recruitment for medical and non medical staff
-
FOI/2022/0392 - Replacement of patient trolleys
-
FOI/2022/0393 - COVID-19 patient treatment between 16/03/2020 - 16/06/2020
-
FOI/2022/0399 - Staff networks at the Trust
-
FOI/2022/0402 - Breast Cancer patients (any stage) treatments
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0408 - Date UCLH became smoke-free
-
FOI/2022/0412 - Mental health inpatient facilities
-
FOI/2022/0413 - Head and neck cancer and urothelial cancer patients treatment and clinical trials